Research topic: Managing compassionate therapy—the role of the virtual clinic

Ward, Marc

doi:10.1111/jgh.13371

Cited by 2 publications

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Assessment of patients' clinical response to biological therapies, including therapeutic monitoring for possible drug side effects, potential complications, clinical and biochemical response, can be undertaken by the IBD nurse following agreed protocols either at the time of administration, or at follow-up [203]. Some centres undertake this multidisciplinary review and management of patients on biologics via virtual biologics clinics [204,205].…”

Section: Biological Therapies N-ecco Statement 2kmentioning

confidence: 99%

Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn’s Disease or Ulcerative Colitis

Kemp

Dibley

Chauhan

et al. 2018

Journal of Crohn's and Colitis

129

150

View full text Add to dashboard Cite

This is the second Nurse European Crohns and Colitis (N-ECCO) consensus statements document addressing inflammatory bowel disease (IBD) nursing across Europe. N-ECCO continues to be an active member of European Crohns and Colitis Organisation (ECCO), providing education and networking opportunities for nurses across Europe within three designated nurse sessions, N-ECCO Network Meeting, N-ECCO School and the N-ECCO Research Forum, in addition to e-learning and podcasts. 1.1 Aim The over-arching aim of ECCO is to improve the care of patients with IBD through the development of guidelines, education and research. Current evidence is fundamental to enable N-ECCO to meet this progressive aim. This document updates the first N-ECCO consensus statements based on the 'ideal' standard of care [1], and provides additional statements and evidence supporting contemporary IBD nursing practice, whilst acknowledging the extensive variety in IBD nursing practice across Europe [2].

show abstract

Section: Biological Therapies N-ecco Statement 2kmentioning

confidence: 99%